Skip to main content

Table 1 Characteristics of the heart donors

From: Evidence for a lack of inotropic and chronotropic effects of glucagon and glucagon receptors in the human heart

Heart No

Age

Sex

HF

TABTR (mins.)

Diagnosis

Treatment

1

55

F

 + 

 − 

HCM, HT,AF

Acenocumarol, Bisoprolol, Sacubitril/Valsartan, Spironolactone, Furosemide

2

64

F

 + 

 − 

HCM, AF, Hypothyroidism

Acenocumarol, Bisoprolol, Bumetanide, Spironolactone, Levothyroxine

3

41

M

 + 

 − 

Autoinmune myocarditis

Dobutamine, Levosimendan

4

55

M

 + 

 − 

IDC, OSA, Hypothyroidsm

Bisoprolol, Eplerenone, Furosemide, Diazepam, Sacubitril/Valsartan, Levothyroxine

5

67

M

 + 

 − 

FDM, Stroke, CKD, AF

Furosemide, Bisoprolol, Eplerenone, Sacibitril/Valsartan, Dabigatran

6

70

F

 − 

20

TBI

 − 

7

63

M

 − 

90

TBI, Prolapsed disc, DLP

Tramadol. Paracetamol, Statins

8

69

F

 − 

120

CKD, HT, DLP

Zolpidem, Furosemide, Doxazosin, Amlodipine, Bisoprolol, Statins

9

71

M

 − 

25

Subaracnoid hemorrage, AF

Acenocumarol, Bisoprolol

10

42

M

 − 

160

TBI, Smoker

 − 

  1. HF Heart Failure, TABTR Time before tissues retrieval, F Female, M Male, HT Hypertension, AF Atrial Fibrillation, DLP Dislipemia, HCM Hypertrophic Cardiomyopathy, CKD Cronic Kidney disease, OSA Obstructive Sleep apnoea, FDM Familiar dilated cardiomyopathy, TBI Traumatic brain injury; IDC Ischaemic dilated cardiomyopathy